At a glance
ClinicalIndex Comparison RecordN/ACompleted· 80 enrolled
Drug / intervention
Puros® Dermis versus Alloderm®device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multi-center, Post-market, Prospective, Randomized, Examiner-Only-Masked Study of Root Coverage With Acellular Dermal Matrix: Puros® Dermis Versus Alloderm®
In Brief
A clinical study evaluating Puros® Dermis versus Alloderm® for Gingival Recession. Completed, enrolled 80 participants across 4 sites.
Detailed Summary
The purpose of the study is to evaluate whether clinical parameters for Puros Dermis are, at minimum, equivalent when compared to AlloDerm, the current industry standard, for the treatment of single, non-adjacent Miller's Class I or II gingival recession.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGingival Recession
CountriesUnited States
CollaboratorsZimmer Dental
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 2009
Enrollment StartAug 2009
Primary CompletionApr 2012
Study CompletionJun 2012
TodayJul 2026
First PostedApr 15, 2009
Enrollment StartAug 1, 2009
Primary CompletionApr 1, 2012
Study CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 17.2 years ago
Interventions
Puros® Dermis versus Alloderm®device
Puros Dermis and Alloderm (both Allograft Tissue Matrix)